The Utility and Limitations of FRAX: A US Perspective

Nguyen TV, Center JR, Eisman JA: Osteoporosis: underrated, underdiagnosed and undertreated. Med J Aust 2004, 180:S18–S22.

Delmas PD, van de Langerijt L, Watts NB, et al.: Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study. J Bone Miner Res 2005, 20:557–563.

Vestergaard P, Rejnmark L, Mosekilde L: Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark. Osteoporos Int 2005, 16:134–141.

Iba K, Takada J, Hatakeyama N, et al.: Underutilization of antiosteoporotic drugs by orthopedic surgeons for prevention of a secondary osteoporotic fracture. J Orthop Sci 2006, 11:446–449.

Siris ES, Chen YT, Abbott TA, et al.: Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 2004, 164:1108–1112.

Wainwright SA, Marshall LM, Ensrud KE, et al.: Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 2005, 90:2787–2793.

van der Klift M, de Laet CE, McCloskey EV, et al.: Risk factors for incident vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res 2004, 19:1172–1180.

Sornay-Rendu E, Munoz F, Garnero P, et al.: Identification of osteopenic women at high risk of fracture: the OFELY Study. J Bone Miner Res 2005, 20:1813–1819.

Kanis JA, Johnell O, Oden A, et al.: Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 2001, 12:989–995.

• Kanis JA, Johnell O, De Laet C, et al.: A meta-analysis of previous fracture and subsequent fracture risk. Bone 2004, 35:375–382. This paper demonstrates the importance of a history of previous fracture as a risk factor for fracture independent of BMD.

• Kanis JA, Johansson H, Oden A, et al.: A family history of fracture and fracture risk: a meta-analysis. Bone 2004, 35:1029–1037. This paper demonstrates the importance of family history of fracture as a risk factor for fracture independent of BMD.

De Laet C, Kanis JA, Oden A, et al.: Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 2005, 16:1330–1338.

• Kanis JA, Johansson H, Oden A, et al.: A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004, 19:893–899. This paper demonstrates the importance of prior corticosteroid use as a risk factor for fracture independent of BMD.

Kanis JA, Borgstrom F, De Laet C, et al.: Assessment of fracture risk. Osteoporos Int 2005, 16:581–589.

Kanis JA, Johnell O, Oden A, et al.: Smoking and fracture risk: a meta-analysis. Osteoporos Int 2005, 16:155–162.

• Kanis JA, Johansson H, Johnell O, et al.: Alcohol intake as a risk factor for fracture. Osteoporos Int 2005, 16:737–742. This paper demonstrates alcohol intake as a risk factor for fracture independent of BMD.

Kanis JA, Johnell O, Oden A, et al.: FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008, 19:385–397.

Kanis JA, Oden A, Johansson H, et al.: FRAX and its applications to clinical practice. Bone 2009, 44:734–743.

National Osteoporosis Foundation: Clinician’s Guide to Prevention and Treatment of Osteoporosis. Available at http://www.nof.org/professionals/Clinicians_Guide.htm . Accessed October 28, 2009.

National Osteoporosis Foundation, International Society for Clinical Densitometry: National Osteoporosis Foundation (NOF)/ International Society for Clinical Densitometry (ISCD) FRAX Implementation Guide. Available at http://www.iscd.org/Visitors/pdfs/FRAXImplementationGuide_000.pdf . Accessed November 25, 2009.

Lewiecki EM: Review of guidelines for bone mineral density testing and treatment of osteoporosis. Curr Osteoporos Rep 2005, 3:75–83.

Kanis JA, Torgerson D, Cooper C: Comparison of the European and USA practice guidelines for osteoporosis. Trends Endocrinol Metab 2000, 11:28–32.

Physician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2003.

Kanis JA, Oden A, Johnell O, et al.: The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007, 18:1033–1046.

Watts NB, Ettinger B, LeBoff MS: FRAX facts. J Bone Miner Res 2009, 76:1–3.

Jones G, Nguyen TV, Sambrook PN, et al.: Symptomatic fracture incidence in elderly men and women. The Dubbo Osteoporosis Epidemiology Study (DOES). Osteoporos Int 1994, 4:277–282.

Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN: Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol 1996, 144:255–263.

Fujiwara S, Kasagi F, Yamada M, Kodama K: Risk factors for hip fracture in Japanese cohort. J Bone Miner Res 1997, 12:998–1004.

Fujiwara S, Fumiyoshi K, Masunari N, et al.: Fracture prediction from bone mineral density in Japanese men and women. J Bone Miner Res 2003, 18:1547–1553.

O’Neill TW, Felsenberg D, Varlow J, et al.: The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 1996, 11:1010–1017.

Felsenberg D, Silman AJ, Lunt M, et al.: Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 2002, 17:716–724.

Ismail AA, Pye SR, Cockerill WC, et al.: Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int 2002, 13:565–571.

Robbins JA, Schott AM, Garnero P, et al.: Risk factors for hip fracture in women with high BMD: the EPIDOS study. Osteopor Int 2005, 16:149–154.

Svanborg A: Seventy-year-old people in Gothenburg. A population study in an industrialized Swedish city. II. General presentation of social and medical conditions. Acta Med Scand Suppl 1977, 611:5–37.

Johansson C, Black D, Johnell O, et al.: Bone mineral density is a predictor of survival. Calcif Tissue Int 1998, 63:190–196.

Stenstrom M, Olsson JO, Mellstrom D: Thyroid hormone replacement is not related to increased risk of osteoporosis. Osteoporos Int 2000, 11(Suppl 2):S144.

Johansson H, Oden A, Johnell O, et al.: Optimization of BMD measurements to identify high risk groups for treatment—a test analysis. J Bone Miner Res 2004, 19:906–913.

Honkanen R, Kroger H, Tuppurainen M, et al.: Fractures and low axial bone density in perimenopausal women. J Clin Epidemiol 1995, 48:881–888.

Albrand G, Munoz F, Sornay-Rendu E, et al.: Independent predictors of all osteoporosis related fractures in healthy postmenopausal women: the OFELY study. Bone 2003, 32:78–85.

Sawka AM, Thabane L, Papaioannou A, et al.: Health-related quality of life measurements in elderly Canadians with osteoporosis compared to other chronic medical conditions: a population-based study from the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 2005, 16:1836–1840.

Melton LJ 3 rd, Crowson CS, O’Fallon WM, et al.: Relative contributions of bone density, bone turnover and clinical risk factors to long-term fracture prediction. J Bone Miner Res 2003, 18:312–318.

Melton LJ 3 rd, Atkinson EJ, O’Connor MK, et al.: Bone density and fracture risk in men. J Bone Miner Res 1998, 13:1915–1923.

Nanes MS, Kallen CB: Clinical assessment of fracture risk and novel therapeutic strategies to combat osteoporosis. Fertil Steril 2009, 92:403–412.

•• De Laet C, Oden A, Johansson H, et al.: The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach. Osteoporos Int 2005, 16:313–318. This paper explains how multiple risk factors can be integrated to improve the prediction of fracture risk.

Ettinger B: A personal perspective on fracture risk assessment tools. Menopause 2008, 15:1023–1026.

McCloskey EV, Johansson H, Oden A, et al.: Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo-controlled randomized study. Osteoporos Int 2009, 20:811–817.

Kanis JA, Johansson H, Oden A, McCloskey EV: Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX. Bone 2009, 22:1049–1054.

McCloskey E, Johansson H, Oden A, et al.: Assessment of the effect of bazedoxifene on non-vertebral fracture risk. J Bone Miner Res 24 (Suppl 1). Available at http://www.asbmr.org/Meetings/AnnualMeeting/AbstractDetail.aspx?aid=6c55b263-692e-4a37-b807-f7a153641564 . Accessed August 2010.

Ettinger B, Black Dm, Mitlak BH, et al.: Reduction in vertebral fracture risk in postmenopausal women with osteoporosis with raloxifene: results from a 3 year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) investigators. JAMA 1999, 282:637–645.

Kanis JA, Johnell O, Oden A, et al.: Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden. Osteoporos Int 2005, 16:6–14.

Lewiecki EM, Watts NB: New guidelines for the prevention and treatment of osteoporosis. South Med J 2009, 102:175–179.

Kanis JA on behalf of the World Health Organization Scientific group: Assessment of Osteoporosis at the Primary Health-Care Level. Technical Report. Sheffield, UK: Edited by the World Health Organization Collaborating Centre for Metabolic Bone Diseases. Printed by the University of Sheffield; 2007.

Cummings S, Melton L: Epidemiology and outcomes of osteoporotic fractures. Lancet 2002, 359:1761–1767.

Black DL, Dalziel R, Young D, Shimmin A: Early results of primary Birmingham hip resurfacings: an independent prospective study of the first 230 hips. J Bone Joint Surg Br 2005, 87:324–329.

Brown JP, Josse RG; Scientific Advisory Council of the Osteoporosis Society of Canada: 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002, 167(10 Suppl):S1–S34.

Pluskiewicz W, Adamczy KP, Franek E, et al.: Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al.—Conformity between methods and their clinical utility. Bone 2010, 46:1661-1667.

Plumijm S, Koes B, de Laet C, et al. : A simple risk score for the assessment of absolute fracture risk in general practice based on two longitudinal studies. J Bone Miner Res 2009, 24:768–774.

Galesic M, Garcia-Retamero R: Statistical numeracy for health: a cross-cultural comparison with probabilistic national samples. Arch Intern Med 2010, 170:462–468.

Ettinger B, Hillier TA, Pressman A, et al.: Simple computer model for calculating and reporting 5-year osteoporotic fracture risk in postmenopausal women. J Womens Health (Larchmt) 2005, 14:159–171.

Sheridan SL, Viera AJ, Krantz MJ, et al.; the Cardiovascular Health Intervention Research and Translation Network Work Group on Global Coronary Heart Disease Risk: The effect of giving global coronary risk information to adults: a systematic review. Arch Intern Med 2010, 170:230–239.